Treatment of hemangiomas of infancy

Dermatologic Therapy

Volumn 18, Issue 2, 2005, Pages 151-159

  Barrio, Victoria R ^a   Drolet, Beth A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MCW Clinic at Froedtert   (United States)

Author keywords

Hemangioma; Management; Therapy; Treatment

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PARACETAMOL; RECOMBINANT ALPHA INTERFERON; TRIAMCINOLONE; VINCRISTINE;

ADRENAL SUPPRESSION; CARDIOMYOPATHY; CHILDHOOD CANCER; CLINICAL FEATURE; CUSHINGOID SYNDROME; FEVER; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; GROWTH RETARDATION; HEMANGIOMA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANCY; INFECTION; MALAISE; REVIEW; WOUND CARE;

HEMANGIOMA; HUMANS; INFANT, NEWBORN; NEOPLASMS, VASCULAR TISSUE;

EID: 21644431713     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.05018.x     Document Type: Review

References (44)

1. Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982: 70: 120-121.
2. Esterly NB. Kasabch-Merritt syndrome in infants. J Am Acad Dermatol 1983: 8: 504-513.
3. Enjorlas O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997: 130: 631-640.
4. Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 1997: 131: 643-646.
5. Frieden IJ. Special symposium: management of hemangiomas. Pediatr Dermatol 1997: 14: 57-58.
6. Williams EF III, Hochman M, Rodgers BJ, Brockbank D, Shannon L, Lam SM. A psychological profile of children with hemangiomas and their families. Arch Facial Plast Surg 2003: 5: 229-234.
7. Tanner JL, Dechert MP, Frieden IJ. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics 1998: 101: 446-452.
8. Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol 2001: 44: 962-972.
9. Achauer BM, Chang CJ, Ander Kam V. Management of hemangiomas of infancy: review of 245 patients. Plast Reconstr Surg 1997: 99: 1301-1308.
10. Kaplan M, Paller AS. Clinical pearl: use of self-adhesive, compressive wraps in the treatment of limb hemangiomas. J Am Acad Dermatol 1995: 32: 117-118.
11. Metz BJ, Rubenstein MC, Levy ML, Metry DW. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 2004: 140: 867-870.
12. Elsas FJ, Lewis AR. Topical treatment of periocular capillary hemangioma. J Pediatr Ophthalmol Strabismus 1994: 31: 153-156.
13. Cruz OA, Zarnegar SR, Myers SE. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology 1995: 102: 2012-2015.
14. Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg 1986: 17: 229-231.
15. Egbert JE, Paul S, Engel WK, Summers CG. High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol 2001: 119: 677-683.
16. Carruthers J, Jevon G, Prendiville J. Localized dystrophic periocular calcification: a complication of intralesional corticosteroid therapy for infantile periocular hemangiomas. Pediatr Dermatol 1998: 15: 23-26.
17. Weiss AH. Adrenal suppression after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol 1989: 107: 518-522.
18. Glatt HJ, Putterman AM, Van Aalst JJ, Levine MR. Adrenal suppression and growth retardation after injection of periocular capillary hemangioma with corticosteroids. Ophthalmic Surg 1991: 22: 95-97.
19. Goyal R, Watts P, Lane CM, Beck L, Gregory JW. Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma. Ophthalmology 2004: 111: 389-395.
20. Sloan GM, Reinisch JF, Nichter LS, Saber WL, Lew K, Morwood DT. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg 1989: 83: 459-467.
21. Chowdri NA, Darzi MA, Fazili Z, Iqbal S. Intralesional corticosteroid therapy for childhood cutaneous hemangiomas. Ann Plast Surg 1994: 33: 46-51.
22. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1991: 87: 582-583.
23. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003: 48: 477-493.
24. Sadan N, Wolach B. Treatment of hemangiomas with high doses of prednisone. J Pediatr 1996: 128: 141-146.
25. Bennett MI, Fleischer AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas. Arch Dermatol 2001: 137: 1208-1213.
26. Boon LM, MacDonald D, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999: 104: 1616-1623.
27. Pokorny JJ, Roth F, Balfour I, Rinehart G. An unusual complication of the treatment of a hemangioma. Ann Plast Surg 2002: 48: 83-37.
28. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Deramtol 2004: 140: 963-969.
29. Aviles R, Boyce TG, Thompson DM. Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas. Mayo Clin Proc 2004: 79: 243-245.
30. Hu B, Lachman R, Phillips J, Peng SK, Sieger L. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. J Pediatr Hematol Oncol 1998: 20: 567-569.
31. Boehm DKK, Obrinsky NL. Treatment of cavernous hemangioma with vincristine. Ann Pharmacother 1993: 27: 98.
32. Moore J, Lee M, Garzon M, et al. Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg 2001: 36: 1273-1276.
33. Payarols JP, Masferrer JP, Bellvert CG. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995: 333: 69.
34. Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004: 11: 99-107.
35. Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002: 24: 459-462.
36. Hurvitz SA, Hurvitz CH, Sloninsky L, Sanford MC. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000: 22: 527-532.
37. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alpha-2a treatment of hemangioma of infancy. J Pediatr 1998: 132: 527-530.
38. Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJH. Spastic diplegia and other motor disturbances in infants recieveing interferon-alpha. Laryngoscope 2004: 114: 1231-1236.
39. Greinwald JH, Burke DK, Bonthius DJ, Bauman NM, Smith RJH. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolayngol Head Neck Surg 1999: 125: 21-27.
40. Dubois J, Hershon L, Carmant L, Belanger S, Leclerc JM, David M. Toxicity profile of interferon alfa-2b in children: a prospective evaluation. J Pediatr 1999: 135: 782-785.
41. Lacour M, Syed S, Linward J, Harper JI. Role of the pulsed dye laser in the management of ulcerated capillary haemangiomas. Arch Dis Child 1996: 74: 161-163.
42. Morelli Jg Tan OT, Yohn JJ, Weston WL. Treatment of ulcerated hemangiomas in infancy. Arch Pediatr Adolesc Med 1994: 148: 1104-1105.
43. David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg 2003: 56: 317-327.
44. Achauer BM, Vander Kam VM. Ulcerated anogenital hemangioma of infancy. Plast Reconstr Surg 1991: 87: 861-866.